Bulk wound tissue surface

The bulk wound tissue surface, commonly known as the wound bed, is the physiological interface where tissue repair processes occur following injury (StatPearls, Wound Healing, 2023). It is a complex, dynamic environment characterized by the presence of various cell types, including fibroblasts and keratinocytes, as well as extracellular matrix (ECM) components and inflammatory mediators (NIH, The Wound Environment, 2021). While not a specific molecular target like a receptor or enzyme, the wound surface is the primary site for topical therapeutic interventions such as antimicrobial agents, enzymatic debriders, and growth factors (Journal of Wound Care, TIME Framework, 2019). These treatments aim to manage the TIME principles: Tissue debridement, Infection control, Moisture balance, and Edge advancement (PubMed, Wound Bed Preparation, 2020). Chronic wound surfaces, such as those in diabetic foot ulcers, often exhibit stalled healing due to persistent inflammation and biofilm formation, making the surface a critical focus for clinical management (Nature Reviews Disease Primers, Diabetic Foot Ulcers, 2017).

Other names

Wound bedWound surfaceUlcer surfaceCutaneous wound siteWound microenvironment

Topical modulation of the wound microenvironment, including antimicrobial action, enzymatic degradation of necrotic tissue, and stimulation of cellular proliferation.